title: Cytokine-induced expression of type II nitric oxide synthase in astrocytes is downregulated by ATP and glutamate.
abstract: Combinations of cytokines and/or phorbol ester induce expression of Type II nitric oxide synthase (NOS) mRNA in astrocyte cultures via protein kinase mediated pathways (Simmons and Murphy: GLIA 11:227, 1994; Fernstein et al.: J Neurochem 62:811, 1994). Agonists that activate receptors linked to protein kinases did not reproduce this effect of cytokines in astrocytes. On the contrary, ATP and glutamate treatment of astrocytes prior to a combination of interleukin-1 beta and interferon-gamma markedly reduced (30-50%) subsequent NOS mRNA expression. The effect was not seen if treatment coincided with or followed cytokine activation, suggesting that ATP and glutamate were not destabilizing NOS mRNA. The effects of ATP and glutamate were additive and could be mimicked by selective receptor agonists, but were insensitive to a specific inhibitor of protein kinase C. The inhibition of cytokine-induced NOS mRNA expression caused by these agents was not the result of interference with the activation/translocation of nuclear factor-Kappa Beta by interleukin-1 beta. These results suggest that exposure of astrocytes to ATP and glutamate, both of which increase markedly in a variety of neuropathologies, could modulate the subsequent responsiveness of these cells to NOS-inducing stimuli. As such, this may be an important regulatory mechanism in the expression of Type II NOS in vivo.
authors.affiliation: Department of Pharmacology, College of Medicine, University of Iowa, Iowa City 52242, USA.
authors.forename: S
authors.initials: S
authors.lastname: Murphy
authors.forename: H L
authors.initials: HL
authors.lastname: Lin
authors.forename: S K
authors.initials: SK
authors.lastname: Park
mesh_terms: D000255:Adenosine Triphosphate / Q000494:pharmacology*; D000818:Animals; D000831:Animals, Newborn; D001253:Astrocytes / Q000187:drug effects / Q000201:enzymology*; D015152:Blotting, Northern; D016207:Cytokines / Q000037:antagonists & inhibitors / Q000494:pharmacology*; D015536:Down-Regulation / Q000187:drug effects*; D018698:Glutamic Acid / Q000494:pharmacology*; D007375:Interleukin-1 / Q000494:pharmacology; D016328:NF-kappa B / Q000096:biosynthesis; D019001:Nitric Oxide Synthase / Q000096:biosynthesis*; D051381:Rats; D018094:Receptors, Metabotropic Glutamate / Q000187:drug effects
chemical_list: D016207:Cytokines; D007375:Interleukin-1; D016328:NF-kappa B; D018094:Receptors, Metabotropic Glutamate; D018698:Glutamic Acid; D000255:Adenosine Triphosphate; D019001:Nitric Oxide Synthase